1. "2017"
  2. "Clifford Hudis"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (16)
  3. Book Section (1)
Groups
  1. Breast Medicine Service (43)
  2. Department of Medicine (43)
  3. Solid Tumor Oncology Division (43)
  4. Survivorship Research (43)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (17)
  6. Surgery (16)

More Groups

People
  1. Clifford Hudis (43)
  2. Larry Norton (16)
  3. Maura Dickler (14)
  4. Monica Morrow (13)
  5. Chau Dang (9)
  6. Edi Brogi (9)

More People

Years
  1. 2017 (43)
Publications
  1. Breast Cancer Research and Treatment (7)
  2. Journal of Clinical Oncology (6)
  3. Cancer Research (5)
  4. Annals of Oncology (2)
  5. Laboratory Investigation (2)
  6. Modern Pathology (2)

More Publications

Publishers
  1. Springer (9)
  2. American Association for Cancer Research (6)
  3. American Society of Clinical Oncology (6)
  4. Oxford University Press (5)
  5. Elsevier Inc. (4)
  6. Nature Publishing Group (3)

More Publishers

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longer follow-up on cardiac safety and distant disease free survival of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab in patients with early-stage HER2-positive breast cancer
    Meeting Abstract

    Wang, R.; Yu, A. F.; Steingart, R.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C.; Dang, C. T.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Seven-year (yr) follow-up of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Tolaney, S. M.; Barry, W. T.; Guo, H.; Dillon, D.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
    Meeting Abstract

    Martin, M.; Loibl, S.; Hyslop, T.; de la Haba-Rodriguez, J.; Aktas, B.; Cirrincione, C.; Carrasco, E. M.; Mehta, K.; Barry, W. T.; Morales, S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
    Meeting Abstract

    Basch, E. M.; Deal, A. M.; Dueck, A. C.; Bennett, A. V.; Atkinson, T. M.; Scher, H. I.; Kris, M. G.; Hudis, C. A.; Sabbatini, P.; Dulko, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The economics of personalized medicine
    Book Section

    Hudis, C.
    In Hays, P. (Eds.) Advancing Healthcare through Personalized Medicine (2017)

    Fulltext@MSK | Save
  • Effects of rapid weight loss on systemic and adipose tissue inflammation and metabolism in obese postmenopausal women
    Journal Article

    Alemán, J. O.; Iyengar, N. M.; Walker, J. M.; Milne, G. L.; Da Rosa, J. C.; Liang, Y.; Giri, D. D.; Zhou, X. K.; Pollak, M. N.; Hudis, C. A.; more...
    Journal of the Endocrine Society (2017)

    Fulltext@MSK | Save
  • RESILIENCE: Phase III randomized, double-blind trial comparing sorafenib with capecitabine versus placebo with capecitabine in locally advanced or metastatic HER2-negative breast cancer
    Journal Article

    Baselga, J.; Zamagni, C.; Gómez, P.; Bermejo, B.; Nagai, S. E.; Melichar, B.; Chan, A.; Mángel, L.; Bergh, J.; Costa, F.; more...
    Clinical Breast Cancer (2017)

    Fulltext@MSK | Save
  • Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302)
    Journal Article

    Hopkins, J. O.; Allred, J.; Hurria, A.; Jatoi, A.; Lafky, J. M.; Cohen, H.; Hudis, C.; Winer, E.; Mandelblatt, J.; Partridge, A.; more...
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save
  • Future cancer research priorities in the USA: A Lancet Oncology Commission
    Journal Article

    Jaffee, E. M.; Dang, C. V.; Agus, D. B.; Alexander, B. M.; Anderson, K. C.; Ashworth, A.; Barker, A. D.; Bastani, R.; Bhatia, S.; Bluestone, J. A.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save